AVISTA HEALTHCARE PARTNERS
AVISTA HEALTHCARE PARTNERS is a Series C+ and buyout fund in the US and Europe writing $130M–$140M checks into outsourced-pharmaceutical-and-medtech-services, consumer-healthcare, medical-devices-and-medtech, specialty-and-generic-pharmaceuticals, distribution-and-diagnostics and healthcare-technology.
- Stages
- Series C+, buyout
- Sectors
- outsourced-pharmaceutical-and-medtech-services, consumer-healthcare, medical-devices-and-medtech, specialty-and-generic-pharmaceuticals, distribution-and-diagnostics, healthcare-technology
- Check size
- $130M–$140M
- Invests in
- US-wide, Europe
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- $8 billion+
- Website
- avistahealthcare.com
Thesis
Avista Healthcare Partners is a private equity firm founded in 2005, specializing in control buyout investments within the middle-market healthcare sector. Their geographic focus spans North America and Europe, targeting companies with strong management, stable cash flows, and growth potential. Avista concentrates on six key sub-sectors: outsourced pharmaceutical and medtech services, consumer healthcare, medical devices and medtech, specialty and generic pharmaceuticals, distribution and diagnostics, and healthcare technology. Their strategy involves driving value through operational improvements, strategic acquisitions, and market expansion, leveraging deep industry expertise and a network of relationships. They employ a proactive, value-added approach with flexible capital solutions and prudent leverage. The firm's latest fund, Avista Healthcare Partners VI, closed in March 2024 with $1.5 billion. As of early 2024, their AUM was approximately $5 billion, with a more recent estimate over $8 billion. They target control investments in businesses generating $5-30 million in EBITDA, with historical deal sizes averaging $130-140 million. Avista has a strong track record, having delivered $12.2 billion in proceeds on $4.2 billion invested capital.
Common questions
Does AVISTA HEALTHCARE PARTNERS invest at the Series C+ stage?
Yes. AVISTA HEALTHCARE PARTNERS lists Series C+ and buyout among the stages it invests in.
What check size does AVISTA HEALTHCARE PARTNERS write?
AVISTA HEALTHCARE PARTNERS writes $130M–$140M checks.
Where does AVISTA HEALTHCARE PARTNERS invest?
AVISTA HEALTHCARE PARTNERS invests in the US and Europe.